Biologics Contract Development Global Market Report 2024

Description

Biologics Contract Development Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biologics contract development market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biologics contract development? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biologics contract development market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Source: Microbial; Mammalian; Others Sources
2) By Indication: Oncology; Immunological disorders; Cardiovascular disorders; Hematological disorders; Others Indications
3) By Product Service: Cell Line Development; Process Development; Others Product Services
Companies Mentioned: WuXi Biologics; Abzena Ltd.; Fujifilm Diosynth Biotechnologies; KBI Biopharma; AGC Biologics
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Biologics contract development involves companies that offer development and manufacturing services for biologics on a contractual basis to pharmaceutical firms. This outsourcing approach allows pharmaceutical companies to concentrate on marketing, research and development (R&D), and brand-building activities while entrusting the manufacturing of biologics to external service providers.

The primary sources for biologics contract development include microbial, mammalian, and other sources. Microbial sources are utilized in the production of various biologics. Biologics contract development caters to various indications, including oncology, immunological disorders, cardiovascular disorders, hematological disorders, and others. The product services offered in biologics contract development encompass cell line development, process development, and other related services.

The biologics contract development market research report is one of a series of new reports from The Business Research Company that provides biologics contract development market statistics, including biologics contract development industry global market size, regional shares, competitors with a biologics contract development market share, detailed biologics contract development market segments, market trends and opportunities, and any further data you may need to thrive in the biologics contract development industry. This biologics contract development market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biologics contract development market size has grown rapidly in recent years. It will grow from $6.94 billion in 2023 to $7.7 billion in 2024 at a compound annual growth rate (CAGR) of 11.0%. The growth observed in the historical period can be attributed to various factors. Firstly, it is linked to the overall growth of the biologics market, which experienced expansion during this period. The rise in biopharmaceuticals, characterized by the development and utilization of biological products in the pharmaceutical industry, played a significant role. The inherent complexity of biologics, both in terms of development and manufacturing, contributed to the demand for specialized contract development services. Patent expirations in the industry also drove companies to explore cost-efficient outsourcing options, leading to increased reliance on biologics contract development services.

The biologics contract development market size is expected to see rapid growth in the next few years. It will grow to $11.68 billion in 2028 at a compound annual growth rate (CAGR) of 11.0%. Anticipated growth in the forecast period is driven by key factors such as the integration of digitalization and data analytics, effective risk management practices, the flexibility and scalability offered by contract development services, a substantial increase in research and development (R&D) investments, and the growing focus on precision medicine and personalized therapies. Major trends expected in this period include the prominence of regenerative medicine, a continued emphasis on robust risk mitigation strategies, a rise in global collaborations, the adoption of advanced technologies, and a significant focus on technological integration within the industry. These trends reflect the dynamic landscape of the contract development sector and the ongoing pursuit of innovative and efficient business practices.

The biologics contract development market is poised for growth due to the increasing prevalence of chronic diseases, necessitating ongoing medical attention and novel drug development. The World Health Organization reported in April 2021 that approximately 71% of global deaths, totaling 41 million people annually, are attributed to chronic diseases. This surge in chronic conditions fuels the demand for biologics, positioning the biologics contract development market for substantial expansion.

A significant upswing in investments in biopharmaceuticals is a key driver of the biologics contract development market. The heightened demand for biopharmaceuticals, encompassing monoclonal antibodies, recombinant proteins, and gene therapies, prompts companies to outsource development activities. In January 2021, FUJIFILM Corporation invested $2 billion to establish a large-scale cell culture production site in the United States, accelerating its biopharmaceutical contract development and manufacturing business. This influx of investment is set to play a pivotal role in propelling the biologics contract development market.

Technological advancements are reshaping the biologics contract development market, with major players incorporating advanced technologies to maintain their market standing. In January 2022, Lonza introduced the bYlok technology platform, designed to facilitate the design and manufacture of bispecific antibodies. This platform addresses challenges related to light-heavy chain mispairing, ensuring high yields, accuracy exceeding 95%, and compatibility with a monoclonal antibody (mAb)-like format. Technological innovation remains a focal point in sustaining competitiveness within the biologics contract development sector.

Major companies operating in the biologics contract development arena are integrating data analytics into their processes, fostering improved monitoring, analysis, and decision-making. This integration of digital technologies enhances efficiency and productivity in biologics development. In October 2022, Evotec SE launched PanHunter, part of the PanOmics data access and analytics technology, which enables advanced patient population stratification and prediction of efficacy and toxicity profiles. This incorporation of data analytics signifies a strategic move towards leveraging digital tools for enhanced insights in the biologics contract development market.

Strategic acquisitions play a pivotal role in reinforcing companies' positions in the biologics contract development market. In February 2022, Recipharm acquired Vibalogics and Arranta Bio, strengthening its presence in advanced therapy medicinal products and expanding virotherapy manufacturing capabilities in the US. Vibalogics and Arranta Bio, both contract development and manufacturing organizations, were pivotal acquisitions contributing to Recipharm's strategic growth in the biologics contract development sector.

Major companies operating in the biologics contract development market report are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc., LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi, and ZymoGenetics Inc.

North America was the largest region in the biologics contract development market share in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the biologics contract development market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biologics contract development market includes revenues earned by entities by sourcing, solid and specialized formulation development, and process analytics development. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12518

1. Executive Summary

2. Biologics Contract Developmen Market Characteristics

3. Biologics Contract Developmen Market Trends And Strategies

4. Biologics Contract Developmen Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Biologics Contract Developmen Market Size and Growth

5.1. Global Biologics Contract Developmen Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Biologics Contract Developmen Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Biologics Contract Developmen Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Biologics Contract Developmen Market Segmentation

6.1. Global Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Microbial
Mammalian
Others Soruces
6.2. Global Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oncology
Immunological disorders
Cardiovascular disorders
Hematological disorders
Others Indications
6.3. Global Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Cell Line Development
Process Development
Others Product Services

7. Biologics Contract Developmen Market Regional And Country Analysis

7.1. Global Biologics Contract Developmen Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Biologics Contract Developmen Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Biologics Contract Developmen Market

8.1. Asia-Pacific Biologics Contract Developmen Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Biologics Contract Developmen Market

9.1. China Biologics Contract Developmen Market Overview
9.2. China Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Biologics Contract Developmen Market

10.1. India Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Biologics Contract Developmen Market

11.1. Japan Biologics Contract Developmen Market Overview
11.2. Japan Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Biologics Contract Developmen Market

12.1. Australia Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Biologics Contract Developmen Market

13.1. Indonesia Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Biologics Contract Developmen Market

14.1. South Korea Biologics Contract Developmen Market Overview
14.2. South Korea Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Biologics Contract Developmen Market

15.1. Western Europe Biologics Contract Developmen Market Overview
15.2. Western Europe Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Biologics Contract Developmen Market

16.1. UK Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Biologics Contract Developmen Market

17.1. Germany Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Biologics Contract Developmen Market

18.1. France Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Biologics Contract Developmen Market

19.1. Italy Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Biologics Contract Developmen Market

20.1. Spain Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Biologics Contract Developmen Market

21.1. Eastern Europe Biologics Contract Developmen Market Overview
21.2. Eastern Europe Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Biologics Contract Developmen Market

22.1. Russia Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Biologics Contract Developmen Market

23.1. North America Biologics Contract Developmen Market Overview
23.2. North America Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Biologics Contract Developmen Market

24.1. USA Biologics Contract Developmen Market Overview
24.2. USA Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Biologics Contract Developmen Market

25.1. Canada Biologics Contract Developmen Market Overview
25.2. Canada Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Biologics Contract Developmen Market

26.1. South America Biologics Contract Developmen Market Overview
26.2. South America Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Biologics Contract Developmen Market

27.1. Brazil Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Biologics Contract Developmen Market

28.1. Middle East Biologics Contract Developmen Market Overview
28.2. Middle East Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Biologics Contract Developmen Market

29.1. Africa Biologics Contract Developmen Market Overview
29.2. Africa Biologics Contract Developmen Market, Segmentation By Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Biologics Contract Developmen Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Biologics Contract Developmen Market, Segmentation By Product Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Biologics Contract Developmen Market Competitive Landscape And Company Profiles

30.1. Biologics Contract Developmen Market Competitive Landscape
30.2. Biologics Contract Developmen Market Company Profiles
- 30.2.1. WuXi Biologics
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Abzena Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Fujifilm Diosynth Biotechnologies
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. BI Biopharma
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AGC Biologics
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Global Biologics Contract Developmen Market Competitive Benchmarking

32. Global Biologics Contract Developmen Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Biologics Contract Developmen Market

34. Biologics Contract Developmen Market Future Outlook and Potential Analysis

34.1 Biologics Contract Developmen Market In 2028 - Countries Offering Most New Opportunities
34.2 Biologics Contract Developmen Market In 2028 - Segments Offering Most New Opportunities
34.3 Biologics Contract Developmen Market In 2028 - Growth Strategies
- 34.3.1 Market Trend Based Strategies
- 34.3.2 Competitor Strategies

35. Appendix

35.1. Abbreviations
35.2. Currencies
35.3. Historic And Forecast Inflation Rates
35.4. Research Inquiries
35.5. The Business Research Company
35.6. Copyright And Disclaimer